AVP and hypertensive disorder: Subcutaneous injection of 3% HTN significantly increased plasma AVP levels in the CTRL + CNO + 3% HTN from the vehicle controls (CTRL + CNO + 0.9% SAL) group (p = 0.016; Tukey’s post hoc analysis).